Sandro Catanzaro Co-Founder DataXu
Finland has pledged to be carbon neutral by 2035. Helsinki’s pledge is set for 2030. Most organizations and states have made pledges that materialize decades away. Finland is therefore leading the way in these important commitments, crucial to fight the existential threat of climate change. Constant innovation, coupled with rapid commercialization, are key to the success of these ambitious goals. Great challenges abound, and these are coupled with numerous opportunities for profitable business outcomes for Finnish companies – opportunities that are not limited to Finland but applicable around the globe.
The MIT Industrial Liaison Program and the MIT Startup Exchange, in collaboration with Aalto University, are conducting a one-day symposium at the Dipoli center in the heart of the university campus. MIT and Aalto University faculty and startups, as well as representatives from Finnish industry, will discuss the business and technology challenges needed to further accelerate sustainable innovation. Launching and commercializing these innovations quickly will ensure that Finnish companies and institutions establish a leadership role in the crucial decades ahead.
As our keynote presentation, Prof. Carlo Ratti will discuss his team’s project, Helsinki’s Hot Heart, award winner of the 2021 Helsinki Energy Challenge. The project is an innovative and transformative energy storage system to provide district heating to the city. The MIT-Aalto Symposium will be an opportunity for the Finnish business community to interact directly with Prof. Ratti on this venture, intimately linked to life in Helsinki. Participants from the business community will also be able to engage with other faculty presenters, startups and with each other, an unusual occurrence in the past two years.
MIT Professional Education and Aalto Executive Education will also offer opportunities for continued engagement and learning for the Finnish corporate community.
The 2023 MIT Asia Roadshow in Osaka presents an opportunity to learn about various MIT-connected startups across diverse industries, including Artificial Intelligence, Energy, Life Sciences, Robotics, Sustainability, and Proptech.
The agenda for the day includes a series of insightful lightning talks, exhibitions showcasing the work of innovative startups, and networking sessions with professionals from MIT-connected startups, as well as the larger industry.
The 2023 MIT Asia Roadshow in Seoul presents an opportunity to learn about various MIT-connected startups across diverse industries, including Artificial Intelligence, Energy, Life Sciences, Robotics, Sustainability, and Proptech.
The 2023 MIT Asia Roadshow in Tokyo presents an opportunity to learn about various MIT-connected startups across diverse industries, including Artificial Intelligence, Energy, Life Sciences, Robotics, Sustainability, and Proptech.
Proctor & Gamble is seeking a technology solution to manage the e2e Creative Content Supply chain.
AI Driven Bloodless Blood Tests Sean (Shunsuke) Matsuoka, Co-Founder & COO, GPx GPx: https://gpx.ai/
In an aging society, the number of heart failure patients is increasing, making the prevention of readmissions and reduction of medical costs critical issues. Remote monitoring using invasive implantable devices has proven effective in reducing heart failure readmissions, but its use remains limited.
To address this, GPx has developed an algorithm that non-invasively predicts signs of heart failure exacerbation. This algorithm was created using clinical trial data from monitoring 245 heart failure patients over 6 months to a year at eight facilities, including the Mayo Clinic in the U.S. The algorithm links digital biomarker data with vital blood tests (NT-proBNP and creatinine) to achieve high-precision prediction and early medical intervention.
Additionally, with a grant of 1.2 billion yen provided through AMED, we are collaborating with the National Cerebral and Cardiovascular Center (Dr. Chisato Izumi) to conduct a clinical trial involving 400 patients starting April 2025. The trial will be conducted at the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University.
Furthermore, at this year's MIT Japan Conference, we will unveil a groundbreaking point-of-care (POC) potassium testing device for the first time. At the conference, we aim to explore the feasibility of applying our technology to other conditions (such as kidney failure, pulmonary arterial hypertension, and cardio-oncology) and to assess the potential for providing algorithm-based services for heart failure patients within Japan.
Scalable production of RNA for agriculture Andrey Zarur, Cofounder & CEO, GreenLight Biosciences Potassium fertilizer innovation Philip Wender, Managing Director, Advanced Potash Technologies Chemiresistive gas sensing for food safety Merry Smith, Senior Scientist, C2Sense Novel dehumidifying material for indoor farms Sorin Grama, Cofounder, Transaera Probiotics for plants Michael Miille, CEO, Joyn Bio [Joyn is a JV between Ginkgo Bioworks and Leaps by Bayer]